At Novogene, the health and safety of our customers and employees remain our priority. In view of the COVID-19 situation, we have stepped up precautionary measures in line with the World Health Organization (WHO) and compliance with local regulatory authorities to protect our employees as we continue to provide our services to customers. Our global offices and laboratories remain fully operational.
As a leading provider of genomic services, we are collaborating with universities, research institutes, clinical hospitals, biopharma companies and centers for disease control and prevention to carry out COVID-19 related research in our fight against the disease.
